Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lap-TAP Block for Opioid Reduction in Bariatric and Foregut Surgery
NCT04655339Phase 3Withdrawn
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jan 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Baylor Scott & White Research Institute. Planned start Jan 2020; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04655339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655339.